Vizient Opens Application Process for 2021 Innovative Technology Exchange

Vizient opened its application process for suppliers who would like to showcase their innovative technology to hospitals from across the country.


Vizient Adds New Essential Medications and Products to its Novaplus Enhanced Supply Program

Vizient announces the expansion of its Novaplus Enhanced Supply Program portfolio, adding six essential medications and two types of thermometers. More

Vizient Earns High Score in Human Rights Campaign’s 2021 Corporate Equality Index

Vizient has received a score of 85 out of 100 on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index. More

Vizient Forecasts 2.67% Increase in Drug Spend in New Pharmacy Market Outlook; Impact of COVID-19 Continues to be Felt Across Healthcare Ecosystem

Formerly named the Drug Price Forecast, the Outlook’s projected increase continues to trend slightly downward, reflecting recent generic entrants to the market as well as increasing adoption of biosimilars.


Vizient Examines Telehealth, Trends in Spine, and Neuromodulation in Latest ‘Medical Device Tech Watch’

Vizient's latest Tech Watch features predictions about the growth of telehealth, shares data on spinal procedures and sheds light on neuromodulation. More

Vizient Invests with PPE Manufacturers to Expand U.S.-based Manufacturing and Help Stabilize Supply

Vizient has entered into agreements with Encompass, Standard Textile and Prestige Ameritech to help expand supply of personal protective equipment.


Vizient Receives Four-year Accreditation Status in Continuing Education from Joint Accreditation

Vizient received accreditation from Joint Accreditation for Interprofessional Continuing Education, the gold standard in medical continuing education.


Vizient Achieves a Microsoft Gold Data Analytics Competency

Vizient attained a gold Data Analytics competency, demonstrating a “best-in-class” ability and commitment to meet Microsoft customers’ evolving needs.


Vizient and Sg2 Release Updated Version of COVID-19 Surge Demand Calculator for Hospitals

Vizient, Inc. and its subsidiary company Sg2 today announced the launch of an updated COVID-19 Surge Demand Calculator.


Vizient Urges Delay of Most Favored Nation Model for Physician-Administered Drugs

Under the MFN Model, hospitals and certain other health care providers will have their Medicare reimbursement for 50 selected prescription drugs reduced to a rate derived from the lowest amount paid by a comparable foreign nation beginning Jan. 1.